University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
NCT Number: NCT06963775
Patients evaluated at Penn Presbyterian Medical Center for traumatic brain injury (TBI), who sign the informed consent, will undergo assessment of electrophysiologic potentials evoked by transcranial magnetic stimulation (TMS), using the Delphi-MD device (QuantalX Neuroscience Ltd., Saba Israel).
Interested in participating?
Request Info18 year and older
All sexes
Observational
Philadelphia, Pennsylvania, 19104, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
for Traumatic Brain Injury (Acute, Subacute, Chronic) group:
Exclusion criteria
for Traumatic Brain Injury (Acute, Subacute, Chronic) group:
Inclusion criteria
for Healthy Control group:
Exclusion criteria
for Healthy Control group:
Delphi-MD utilizes the use of transcranial magnetic stimulation evoked electroencephalography (TMS-EEG) for diagnostic purposes in a wide range of neurological disorders. Delphi-MD includes a magnetic stimulator and coil, an EEG amplifier and electrode cap and software for the acquisition and analysis of the data.
Delphi-MD stimulation protocol includes low intensities (sub motor thresholds) and frequencies over six stimulation sites (bilateral primary motor cortex, and bilateral dorsolateral prefrontal cortex).
Time frame: Day 1
Time frame: Day 1
For single timepoint (day 1).
Ramon Diaz-Arrastia
Other
Assessment of Traumatic Brain Injury Using Transcranial Magnetic Stimulated Evoked Potentials (TMS-EEG)
Acronym: (TMS-EEG)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07521384
Alzheimer Dementia (AD), Alzheimer Disease
Monterrey, Nuevo León, Mexico
View Trial DetailsNCT06973018
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Stockholm, Stockholm County, Sweden
View Trial DetailsNCT07794072
Ataxia, Basal Ganglia Diseases
Milan, Italy
View Trial DetailsNCT02795052
ALS, Alzheimer Disease
Westport, Connecticut, United States
View Trial Details